Filana Therapeutics, Inc.
Ownership
Ownership Structure
Who owns Filana Therapeutics, Inc. (FLNA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.1% of the shares are freely tradable; institutional investors hold 28.7%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Capital Management, LLC | 4.09 | 1,974,981 | +2.3 | 06/30/2026 |
| Two Sigma Investments LLC | 3.54 | 1,711,358 | -14.0 | 06/30/2026 |
| Marshall Wace Asset Management Ltd | 3.31 | 1,597,548 | -20.6 | 06/30/2026 |
| BlackRock Inc | 3.01 | 1,453,561 | +2.8 | 06/30/2026 |
| The Goldman Sachs Group Inc | 1.38 | 668,792 | +1,518.4 | 06/30/2026 |
| Geode Capital Management, LLC | 1.27 | 615,510 | +3.2 | 06/30/2026 |
| D. E. Shaw & Co LP | 1.00 | 485,025 | -13.3 | 06/30/2026 |
| GMT Capital Corp | 0.93 | 450,100 | +0.0 | 06/30/2026 |
| Renaissance Technologies Corp | 0.81 | 389,601 | +19.2 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.83 | 1,365,843 | +0.0 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Barry Richard | President & CEO | 1,337,964 | 832,214 $ | Sep 30, 2026 | indirect |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Barry Richard | President & CEO | Buy | 100,000 | 0.92 | 92,000 |
| Sep 29, 2026 | Barry Richard | President & CEO | Buy | 206,813 | 0.90 | 186,132 |
| Sep 28, 2026 | Barry Richard | President & CEO | Buy | 93,091 | 0.84 | 78,196 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.